Real-World Administrative Claims Analysis Demonstrates That Almost Half of Migraine Patients Discontinue Barbiturate Use After Initiation of Nurtec ODT

Results from this study demonstrate a robust and clinically meaningful reduction in barbiturate use after the initiation of Nurtec ODT, providing an...

Related Keywords

United States ,American ,Noah Rosen ,Katherine Standley ,Jennifer Porcelli ,Mike Beyer ,Biohaven Neuroinnovation ,Exchange Commission On ,World Health Organization ,Drug Administration ,Sam Brown Inc ,Exchange Commission ,Biohaven Pharmaceutical Holding Company Ltd ,Neuroscience Institute Of Great Neck ,American Headache Society ,American Academy Of Neurology ,Prnewswire Biohaven Pharmaceutical Holding Company Ltd ,Pharmaceutical Holding Company ,Northwell Physician Partners ,Neuroscience Institute ,Great Neck ,Medical Director ,American Academy ,Senior Vice President ,Prescribing Information ,Channel Activators ,Private Securities Litigation Reform Act ,Annual Report ,Biohaven Pharmaceutical Ireland ,Biohaven Pharmaceutical Holding Company ,